Literature DB >> 17652387

Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo.

Lizeng Qin1, John R Greenland, Chikaya Moriya, Mark J Cayabyab, Norman L Letvin.   

Abstract

While administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce the local recruitment of activated antigen-presenting cells at the site of vaccine inoculation, this cellular recruitment is associated with a paradoxical decrease in local vaccine antigen expression and vaccine-elicited CD8+ T-cell responses. To clarify why this cytokine administration does not potentiate immunization, we examined the recruited cells and expressed inflammatory mediators in muscles following intramuscular administration of plasmid GM-CSF in mice. While large numbers of dendritic cells and macrophages were attracted to the site of plasmid GM-CSF inoculation, high concentrations of type I interferons were also detected in the muscles. As type I interferons have been reported to damp foreign gene expression in vivo, we examined the possibility that these local innate mediators might decrease plasmid DNA expression and therefore the immunogenicity of plasmid DNA vaccines. In fact, we found that coadministration of an anti-beta interferon monoclonal antibody with the plasmid DNA immunogen and plasmid GM-CSF restored both the local antigen expression and the CD8+ T-cell immunogenicity of the vaccine. These data demonstrate that local innate immune responses can change the ability of vaccines to generate robust adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652387      PMCID: PMC2045443          DOI: 10.1128/JVI.01000-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

Authors:  Dan H Barouch; Sampa Santra; Klara Tenner-Racz; Paul Racz; Marcelo J Kuroda; Joern E Schmitz; Shawn S Jackson; Michelle A Lifton; Dan C Freed; Helen C Perry; Mary-Ellen Davies; John W Shiver; Norman L Letvin
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

Review 2.  Interferons alpha and beta as immune regulators--a new look.

Authors:  C A Biron
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

3.  Imaging transgene expression in live animals.

Authors:  A Honigman; E Zeira; P Ohana; R Abramovitz; E Tavor; I Bar; Y Zilberman; R Rabinovsky; D Gazit; A Joseph; A Panet; E Shai; A Palmon; M Laster; E Galun
Journal:  Mol Ther       Date:  2001-09       Impact factor: 11.454

4.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

Authors:  A Le Bon; G Schiavoni; G D'Agostino; I Gresser; F Belardelli; D F Tough
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

5.  Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

Authors:  M Bauer; V Redecke; J W Ellwart; B Scherer; J P Kremer; H Wagner; G B Lipford
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

6.  Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.

Authors:  M Arpinati; C L Green; S Heimfeld; J E Heuser; C Anasetti
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

7.  Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.

Authors:  G Gribaudo; S Ravaglia; M Gaboli; M Gariglio; R Cavallo; S Landolfo
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

8.  Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.

Authors:  J S Harms; G A Splitter
Journal:  Hum Gene Ther       Date:  1995-10       Impact factor: 5.695

9.  IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

Authors:  M K Levings; R Sangregorio; F Galbiati; S Squadrone; R de Waal Malefyt; M G Roncarolo
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

10.  CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells.

Authors:  H Nakano; M Yanagita; M D Gunn
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  6 in total

1.  A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques.

Authors:  Alan D Curtis; Kara Jensen; Koen K A Van Rompay; Rama R Amara; Pamela A Kozlowski; Kristina De Paris
Journal:  J Med Primatol       Date:  2018-09-11       Impact factor: 0.667

2.  Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice.

Authors:  Hui Chen; Na Gao; Dongying Fan; Jiangman Wu; Junping Zhu; Jieqiong Li; Juan Wang; Yanlei Chen; Jing An
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

3.  Regulatory T Cells Modulate DNA Vaccine Immunogenicity at Early Time via Functional CD4(+) T Cells and Antigen Duration.

Authors:  Lizeng Qin; Guosheng Jiang; Jinxiang Han; Norman L Letvin
Journal:  Front Immunol       Date:  2015-09-29       Impact factor: 7.561

4.  Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3.

Authors:  Inger Øynebråten; Jorma Hinkula; Agnete B Fredriksen; Bjarne Bogen
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

5.  Blocking T-cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity.

Authors:  Jamie F S Mann; Paul F McKay; Katja Klein; Joshua Pankrac; John S Tregoning; Robin J Shattock
Journal:  Immunology       Date:  2021-12-12       Impact factor: 7.215

6.  Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.

Authors:  Kelly M Shepardson; Kyle Larson; Rachelle V Morton; Justin R Prigge; Edward E Schmidt; Victor C Huber; Agnieszka Rynda-Apple
Journal:  MBio       Date:  2016-05-03       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.